Virus News and Research

Latest Virus News and Research

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

Researchers explored probable humoral immune mechanisms related to EBV curtailment, besides neutralization, by a systematic emphasis on antibody fragment crystallizable-functional activities over the course of EBV infections.

9 Sep 2022

MolGen Joins Life Sciences & Health Dutch Economic Mission to California

MolGen B.V. of Veenendaal (NL), participates in the 24th Annual Conference of the European Society for Clinical Virology (ESCV) held in Manchester, United Kingdom on 7-10 September 2022.

From MolGen 9 Sep 2022

All SARS-CoV-2 variants neutralized by a potent new antibody

Researchers describe a mouse model used to generate a VH1-2 heavy chain (HC)- and Vκ1-33 light chain (LC)-based recombinant antibody that broadly neutralized all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including the newly emergent Omicron sub-variant BA.5.

9 Sep 2022

Can preclinical COVID-19 models help unlock mystery of long-COVID?

In a recently published article in the journal PLOS PATHOGENS, scientists have summarized acute and prolonged clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review also provides an overview of the potency and utility of preclinical animal models to understand the mechanistic details of acute and long coronavirus disease 2019 (COVID-19).

8 Sep 2022

Stem cell-derived liver cell model could be a valuable tool for future studies on Ebola virus

Ebola virus causes serious infections in humans and in fatal cases, damage and dysfunction of the liver is often present, suggesting that the liver plays a decisive role in disease outcome.

8 Sep 2022

Using wastewater-based epidemiology to monitor monkeypox

Monkeypox, a virus that causes painful rashes and flu-like symptoms, is spreading rapidly throughout many parts of the world, including the U.S. To get a fast understanding of how the virus is moving through communities, researchers reporting in ACS' Environmental Science & Technology Letters suggest turning to wastewater epidemiology.

8 Sep 2022

Promising anti-cancer agent may also prevent SARS-CoV-2 from replication

Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.

8 Sep 2022

NIH issues funding opportunities to support the development of new COVID-19 diagnostics

The National Institutes of Health has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 tests, with a major focus on accessibility.

8 Sep 2022

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses has begun enrolling adult volunteers.

8 Sep 2022

SARS-CoV-2 infection leaves significant effects long after the patient is symptom-free

The immune cells of patients who received hospital care for COVID-19 early in the pandemic were still affected six months later.

8 Sep 2022

Researchers harness stem cells to study how Ebola virus infects and damages the liver

The Ebola virus was first identified in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, there have been periodic outbreaks of Ebola Virus Disease (EVD), mostly in Africa, resulting in 13,700 deaths worldwide.

8 Sep 2022

Biosynthetic proteins show promise as SARS-CoV-2 antivirals targeting spike protein

Researchers developed an αRep series specific to the RBD of the SARS-CoV-2 S, which could easily adapt to work stably against SARS-CoV-2 variants at a low cost.

8 Sep 2022

Researchers review the epidemiology, clinical character, treatment, and prevention of human monkeypox

Researchers reviewed the epidemiology, clinical character, treatment, and prevention of human monkeypox.

8 Sep 2022

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

Researchers assessed the role of the gut microbiome in human health and disease.

8 Sep 2022

Study estimates prevalence of long-COVID with variant BA.5 in the U.S.

...

8 Sep 2022

How air passenger ignorance and behaviour aided SARS-CoV-2's entry into the UK

A new study under review at the Scientific Reports journal and currently posted to the Research Square* preprint server aimed to analyze the increased risk of COVID-19 spreading due to human behavior associated with travel among UK air travelers that have flown during the pandemic.

7 Sep 2022

How does SARS-CoV-2 infection impact fertility in men?

In a recent review published in the journal Endocrines, researchers summarized existing literature findings on the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on the male reproductive system and fertility.

7 Sep 2022

NIH animal study combines Paxlovid with Lagevrio against SARS-CoV-2 Delta

In a recent study posted to the bioRxiv* preprint server, researchers at the U.S National Institutes of Health demonstrated the efficacy of molnupiravir and nirmatrelvir, two oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals in the rhesus macaque model, the closest proxy to humans.

7 Sep 2022

Study indicates that HIV-infected and uninfected patients have similar monkeypox illness outcomes

In a recent study published in the journal HIV Medicine, German researchers evaluated the clinical characteristics of Monkeypox virus (MPXV) infections in people with and without human immunodeficiency virus (HIV) infection.

7 Sep 2022

MD Anderson and Virogin Biotech partner to accelerate the development of investigational treatments for advanced cancers

The University of Texas MD Anderson Cancer Center and Virogin Biotech today announced a strategic collaboration to accelerate the development of investigational treatments, including oncolytic viruses and immunotherapies, for patients with advanced cancers.

7 Sep 2022

Virus News and Research

Latest Virus News and Research

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

MolGen Joins Life Sciences & Health Dutch Economic Mission to California

All SARS-CoV-2 variants neutralized by a potent new antibody

Can preclinical COVID-19 models help unlock mystery of long-COVID?

Stem cell-derived liver cell model could be a valuable tool for future studies on Ebola virus

Using wastewater-based epidemiology to monitor monkeypox

Promising anti-cancer agent may also prevent SARS-CoV-2 from replication

NIH issues funding opportunities to support the development of new COVID-19 diagnostics

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

SARS-CoV-2 infection leaves significant effects long after the patient is symptom-free

Researchers harness stem cells to study how Ebola virus infects and damages the liver

Biosynthetic proteins show promise as SARS-CoV-2 antivirals targeting spike protein

Researchers review the epidemiology, clinical character, treatment, and prevention of human monkeypox

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

Study estimates prevalence of long-COVID with variant BA.5 in the U.S.

How air passenger ignorance and behaviour aided SARS-CoV-2's entry into the UK

How does SARS-CoV-2 infection impact fertility in men?

NIH animal study combines Paxlovid with Lagevrio against SARS-CoV-2 Delta

Study indicates that HIV-infected and uninfected patients have similar monkeypox illness outcomes

MD Anderson and Virogin Biotech partner to accelerate the development of investigational treatments for advanced cancers

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in